BIOMAT Database Logo BIOMAT Database Logo

Maintenance therapy of intermittent high-dose methotrexate in acute childhood leukemia--4-year survivals. 1978

T Fujimoto, and K Sasaki, and N Goya

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Fujimoto, and K Sasaki, and N Goya
Maintenance therapy and pharmacokinetics of intermittent high-dose methotrexate in acute childhood leukemia.
February 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
T Fujimoto, and K Sasaki, and N Goya
High dose methotrexate in acute lymphocytic leukemia in childhood.
May 1978, Acta paediatrica Scandinavica,
T Fujimoto, and K Sasaki, and N Goya
[High dosage intermittent methotrexate therapy in acute childhood leukemias].
February 1966, Deutsche medizinische Wochenschrift (1946),
T Fujimoto, and K Sasaki, and N Goya
[Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
January 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
T Fujimoto, and K Sasaki, and N Goya
The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia.
January 2024, Leukemia & lymphoma,
T Fujimoto, and K Sasaki, and N Goya
Rational use of methotrexate in maintenance therapy of childhood acute lymphoblastic leukemia.
February 1992, Chinese medical journal,
T Fujimoto, and K Sasaki, and N Goya
High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study.
December 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Fujimoto, and K Sasaki, and N Goya
Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.
January 1987, Haematology and blood transfusion,
T Fujimoto, and K Sasaki, and N Goya
Hemostatic side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.
January 2004, Pediatric hematology and oncology,
T Fujimoto, and K Sasaki, and N Goya
Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood.
January 1987, NCI monographs : a publication of the National Cancer Institute,
Copied contents to your clipboard!